Table 1 Association between ZFP57 and MEST expression and clinicopathologic features of patients with breast cancer (n = 80)
Characteristics | Number | Low ZFP57 | High ZFP57 | P value | Low MEST | High MEST | P value |
|---|---|---|---|---|---|---|---|
Age (years) | 0.317 | 0.133 | |||||
≤60 | 58 | 31 | 27 | 32 | 26 | ||
>60 | 22 | 9 | 13 | 8 | 14 | ||
Tumour size (cm) | 0.000 | 0.044 | |||||
≤3 | 43 | 10 | 33 | 26 | 17 | ||
>3 | 37 | 30 | 7 | 14 | 23 | ||
Lymph node metastasis | 0.370 | 0.179 | |||||
Positive | 38 | 17 | 21 | 22 | 16 | ||
Negative | 42 | 23 | 19 | 18 | 24 | ||
T grade | 0.330 | 0.021 | |||||
I/II | 69 | 33 | 36 | 38 | 31 | ||
III/IV | 11 | 7 | 4 | 2 | 9 | ||
Receptor status | 0.073 | 0.076 | |||||
(ER+ or PR+)/(HER2- or HER2 missing) | 46 | 18 | 28 | 27 | 19 | ||
ER−/PR−/(HER2− or missing) | 10 | 6 | 4 | 2 | 8 | ||
HER2 + | 24 | 16 | 8 | 11 | 13 | ||
Ki67 | 0.000 | 0.025 | |||||
Low | 40 | 11 | 29 | 25 | 15 | ||
High | 40 | 29 | 11 | 15 | 25 |
